Page last updated: 2024-09-03

rb 6145 and nsc 600032

rb 6145 has been researched along with nsc 600032 in 1 studies

Compound Research Comparison

Studies
(rb 6145)
Trials
(rb 6145)
Recent Studies (post-2010)
(rb 6145)
Studies
(nsc 600032)
Trials
(nsc 600032)
Recent Studies (post-2010) (nsc 600032)
380242114

Protein Interaction Comparison

ProteinTaxonomyrb 6145 (IC50)nsc 600032 (IC50)
Tubulin alpha-1A chainSus scrofa (pig)2.3
Tubulin beta chainSus scrofa (pig)3.5

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chaplin, DJ; Davis, P; Devkota, L; Gerberich, JL; Hamel, E; Kuch, B; MacDonough, MT; Mason, RP; Mondal, D; Pinney, KG; Ramirez, AJ; Shi, Z; Strecker, TE; Trawick, ML; Wang, Y; Winn, BA1

Other Studies

1 other study(ies) available for rb 6145 and nsc 600032

ArticleYear
Bioreductively Activatable Prodrug Conjugates of Combretastatin A-1 and Combretastatin A-4 as Anticancer Agents Targeted toward Tumor-Associated Hypoxia.
    Journal of natural products, 2020, 04-24, Volume: 83, Issue:4

    Topics: A549 Cells; Animals; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Hypoxia; Colchicine; Drug Screening Assays, Antitumor; Female; Humans; Mice; Mice, Inbred BALB C; NADPH-Ferrihemoprotein Reductase; Prodrugs; Stilbenes; Tubulin

2020